Arrowhead Research | Kortsiktig Gjeld

Current Liabilities Endring Dato
Agios Pharmaceuticals USD 51.69M 16.26M 2024-03
Alnylam Pharmaceuticals USD 941.71M 26.08M 2024-03
Arrowhead Research USD 65.18M 1.45M 2024-03
Incyte USD 1.4B 156.07M 2024-03
Ionis Pharmaceuticals USD 327.65M 120.44M 2024-03
Ligand Pharmaceuticals USD 17.82M 1.04M 2024-03
Merck USD 25.1B 2.01B 2024-03
Moderna USD 2.38B 635M 2024-03
Novartis USD 29.29B 2.9B 2024-03
Sarepta Therapeutics USD 608.71M 157.97M 2024-03
TG Therapeutics USD 99.68M 42.01M 2024-03
Ultragenyx Pharmaceutical USD 245.58M 8.4M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03
Xencor USD 79.4M 5.31M 2024-03



Arrowhead Research Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.